Cargando…
A phase 1, first-in-human study of (18)F-GP1 positron emission tomography for imaging acute arterial thrombosis
BACKGROUND: (18)F-GP1 is a novel positron emission tomography (PET) tracer that targets glycoprotein IIb/IIIa receptors on activated platelets. The study objective was to explore the feasibility of directly imaging acute arterial thrombosis (AAT) with (18)F-GP1 PET/computed tomography (PET/CT) and t...
Autores principales: | Chae, Sun Young, Kwon, Tae-Won, Jin, Soyoung, Kwon, Sun U., Sung, Changhwan, Oh, Seung Jun, Lee, Sang Ju, Oh, Jungsu S., Han, Youngjin, Cho, Yong-Pil, Lee, Narae, Kim, Ji Young, Koglin, Norman, Berndt, Mathias, Stephens, Andrew W., Moon, Dae Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323046/ https://www.ncbi.nlm.nih.gov/pubmed/30617563 http://dx.doi.org/10.1186/s13550-018-0471-8 |
Ejemplares similares
-
Commentary to (18)F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
por: Stephens, Andrew W., et al.
Publicado: (2018) -
Different subregional metabolism patterns in patients with cerebellar ataxia by (18)F-fluorodeoxyglucose positron emission tomography
por: Oh, Minyoung, et al.
Publicado: (2017) -
GMP-Compliant Radiosynthesis of [(18)F]GP1, a Novel PET Tracer for the Detection of Thrombi
por: Hugenberg, Verena, et al.
Publicado: (2021) -
Comparison of diagnostic sensitivity of [(18)F]fluoroestradiol and [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
por: Chae, Sun Young, et al.
Publicado: (2020) -
Clinicopathological characteristics of primary central nervous system lymphoma with low (18)F-fludeoxyglucose uptake on brain positron emission tomography
por: Kim, Hye Ok, et al.
Publicado: (2020)